McGuire Investment Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

McGuire Investment Group’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-228,810	Closed	-$2.06M	–	126
2021 Q3	$2.06M	Sell	228,810 -16,908	-7%	-$167K	0.39%	46
2021 Q2	$2.94M	Sell	245,718 -27,083	-10%	-$307K	0.56%	45
2021 Q1	$3.42M	Buy	272,801 +242,146	+790%	+$3.26M	0.72%	42
2020 Q4	$478K	Buy	30,655 +8,945	+41%	+$105K	0.12%	70
2020 Q3	$205K	Sell	21,710 -1,090	-5%	-$11.8K	0.06%	94
2020 Q2	$204K	Buy	22,800 +1,000	+5%	+$9.28K	0.07%	84
2020 Q1	$139K	Buy	21,800 +1,000	+5%	+$7.42K	0.06%	79
2019 Q4	$174K	Buy	20,800 +8,700	+72%	+$80K	0.05%	90
2019 Q3	$110K	Buy	+12,100	New	+$136K	0.04%	95

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LOAMS

Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

McGuire Investment Group's SGMO Position: Q4 2021 in Review

McGuire Investment Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2021, closing a stake of 228,810 shares — an estimated $2.06M sold.

McGuire Investment Group first reported a position in SGMO in Q3 2019 and held it in 9 quarters. The position peaked at $3.42M in Q1 2021. 193 funds tracked by Wall St. Rank hold SGMO as of Q4 2021.

McGuire Investment Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2021 after selling out during the quarter.
McGuire Investment Group sold 228,810 SANGAMO THERAPEUTICS INC shares in Q4 2021, an estimated $2.06M.
McGuire Investment Group first reported a position in SANGAMO THERAPEUTICS INC in Q3 2019 and held it in 9 quarters.
McGuire Investment Group's SANGAMO THERAPEUTICS INC position peaked at $3.42M in Q1 2021.
193 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2021.

Based on McGuire Investment Group's 13F filing for Q4 2021, filed 13 Jan 2022.